$MRK —FDA approves q6w dosing for Keytruda monotherapy:

https://t.co/IraDMuwyXx

Alternative regimen—&gt;400mg q6W instead of 200mg q3w. This is a timely FDA action insofar as the q6w regimen reduces by 50% the no. of times a patient needs to visit the clinic during the pandemic.